Patients With CKD Face High Symptom Burden at End of Life

This article originally appeared here.
Share this content:
Patients With CKD Face High Symptom Burden at End of Life
Patients With CKD Face High Symptom Burden at End of Life

FRIDAY, March 9, 2018 (HealthDay News) -- Patients with advanced kidney disease face a substantial symptom burden in the last 12 months of life, according to a small study published online Feb. 28 in the Journal of Renal Care.

Ann Bonner, Ph.D., from the Queensland University of Technology in Brisbane, Australia, and colleagues describe symptoms, quality of life, and supportive care needs in the anticipated 12-month period prior to death in 19 adults with chronic kidney disease, stages 4 or 5.

The researchers found that the most prevalent symptoms differed from the most troublesome symptoms. The median age of the patients was 78 years, and most were male (63 percent). Of these, 10 were receiving dialysis, and seven died during the study. The median Australian Karnofsky Performance Scale score did not change over time. Quality of life, as measured by the Functional Assessment of Chronic illness Therapy Palliative-14 and the Assessment of Quality of Life 6 Dimensions, remained steady over time. Few supportive care needs were identified.

"Regular assessment of both symptoms and quality of life is warranted particularly if clinical experience indicates that the person is likely to be in their last year of life," the authors write. "Integrated supportive care programs could assist with easing symptom burden during this time."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Global Prevalence of Insufficient Activity 27.5 Percent

Global Prevalence of Insufficient Activity 27.5 Percent

Levels of insufficient physical activity stable between 2001, 2016; increase seen in high-income countries

HTN Tx Intensification Common Upon Discharge in U.S. Vets

HTN Tx Intensification Common Upon Discharge in U.S. ...

Fourteen percent of older adults admitted to hospital for non-cardiac conditions had intensification of tx

Quarterly Canakinumab Reduces Risk for Gout Attacks

Quarterly Canakinumab Reduces Risk for Gout Attacks

Doesn't affect serum uric acid levels over time, but targets interleukin-1β

is free, fast, and customized just for you!




Already a member?

Sign In Now »